Y Intercept (Hong Kong) LTD Mersana Therapeutics, Inc. Transaction History

Y Intercept (Hong Kong) LTD

  • $1.44 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$2.0 - $4.45 $93,558 - $208,166
46,779 New
46,779 $94,000
Q3 2023

Nov 14, 2023
BUY
$1.06 - $3.91 $35,594 - $131,297
33,580 Added 288.27%
45,229 $57,000
Q2 2023

Aug 14, 2023
BUY
$3.08 - $9.55 $35,878 - $111,247
11,649 New
11,649 $38,000

Others Institutions Holding MRSN

# of Institutions
130
Shares Held
104M
Call Options Held
58.5K
Put Options Held
471K
View Full List

About Mersana Therapeutics, Inc.

MRSN Quotes by TradingView
  • Ticker MRSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,169,296
  • Market Cap $56.4M
  • Description
  • Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...
More about MRSN
Track This Portfolio

Track Y Intercept (Hong Kong) LTD Portfolio

Follow Y Intercept (Hong Kong) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email